Cha Albert has filed 6 insider transactions across 1 company since September 2023.
Most recent transaction: a grant/award of 10000 shares of KalVista Pharmaceuticals, Inc. ($KALV) on September 26, 2023.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 26, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Cha Albert | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 11, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Cha Albert | Director | M | Common Stock | 6000 | $6.71 | 6,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 11, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Cha Albert | Director | M | Common Stock | 12000 | $7.88 | 18,000.0000 | 0 | 200.00% | 0.00% |
| Sept. 11, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Cha Albert | Director | S | Common Stock | 18000 | $10.50 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 11, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Cha Albert | Director | M | Employee Stock Option (right to buy) | 6000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 11, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Cha Albert | Director | M | Employee Stock Option (right to buy) | 12000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |